Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | rAd-hCD40L |
Synonyms | |
Therapy Description |
rAd-hCD40L is a recombinant adenovirus vector expressing human CD40LG (CD40L), which activates TNFRSF5 (CD40) signaling and leads to apoptosis and growth inhibition in tumor cells (PMID: 19461675). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
rAd-hCD40L | rAd.CD40L|ISF35 | rAd-hCD40L is a recombinant adenovirus vector expressing human CD40LG (CD40L), which activates TNFRSF5 (CD40) signaling and leads to apoptosis and growth inhibition in tumor cells (PMID: 19461675). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|